The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States
Open accessAbstract
OBJECTIVE: The authors present 12-month and lifetime prevalence, correlates, psychiatric comorbidity, and treatment of nonmedical prescription opioid use (NMPOU) and DSM-5 NMPOU disorder (NMPOUD). METHODS: Data were derived from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) (N = 36,309). RESULTS: Prevalences of 12-month and lifetime NMPOU were 4.1% and 11.3%, exceeding rates in the 2001-2002 NESARC (1.8%, 4.7%). Twelve-month and lifetime rates of DSM-5 NMPOUD were 0.9% and 2.1%. NESARC-III DSM-IV NMPOUD rates (0.8%, 2.9%) were greater than those observed in the 2001-2002 NESARC (0.4% and 1.4%). Rates of NMPOU were greater among men, but no sex differential was observed for NMPOUD. Prevalences of NMPOU and NMPOUD were generally greater among 18- to 64-year-old individuals, whites, and Native Americans, and individuals with lower socioeconomic status. Associations were observed between 12-month and lifetime NMPOU and NMPOUD and other drug use disorders, posttraumatic stress disorder, and borderline, schizotypal, and antisocial personality disorders; persistent depression and major depressive disorder (for NMPOU); and bipolar I disorder (for NMPOUD). Only 5.5% and 17.7% of individuals with 12-month NMPOU and NMPOUD were ever treated. CONCLUSIONS: NMPOU and NMPOUD have considerably increased over the past decade, are associated with a broad array of risk factors and comorbidities, and largely go untreated in the United States. More information on the determinants, characteristics, and outcomes of NMPOU and NMPOUD is needed to support evidence-based interventions and prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major depressive disorder was assoc iated w ith SUDs, particularly drug disorders, as found previously for cannabis, 40,62 nonmedical prescription opioids, 5,57,63 and drug use disorders.41”
From Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States (2018) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
Self-citationDSM-5 criteria for substance use disorders: recommendations and rationale
Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060782 · Cited by 1,622
Self-citationGrant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262
Self-citationCompton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.566 · Cited by 1,152
Self-citationTrends in Opioid Analgesic Abuse and Mortality in the United States
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher‐Bartelson, B., & Green, J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406143 · Cited by 1,140
Martell, B. A., O’Connor, P. G., Kerns, R. D., Becker, W. C., Morales, K. H., Kosten, T. R., & Fiellin, D. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00006 · Cited by 773
Grant, B., Harford, T., Dawson, D., Chou, P., & Pickering, R. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 689
Self-citationSocietal costs of prescription opioid abuse, dependence, and misuse in the United States
Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01075.x · Cited by 644
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s63 · Cited by 638
Medication-Assisted Treatment of Opioid Use Disorder
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 577
Flagged first, then by citations
Research works printed but not linked: 5
- [1]Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education Relieving Pain in American A Blueprint for Transforming Prevention, Care, Education and Research Washington, DC The National Academies Press 2011 22553896
- [32]Hasin DS O’Brien CP Auriacombe M recommendations and rationale Am J Psychiatry 2013 170 8 834 851 23903334 PMC3767415
- [36]Grant BF Goldstein RB Chou SP The Alcohol Use Disorder and Associated Disabilities Interview Schedule – Diagnostic and Statistical Manual of Mental Disorders fifth Edition Version (AUDADIS-5) Rockville, MD National Institute on Alcohol Abuse and Alcoholism 2011
- [39]Hasin DS Aivadyan C Greenstein E Psychiatric Research Interview for Substance Use and Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PRISM-5) Version New York, NY Columbia University, Department of Psychiatry 2011
- [56]Roe CM McNamara AM Motheral BR Gender- and age-related prescription drug use patterns Ann Pharmacother 2002 36 1 30 39 11816254
Cited by
Sorted by citations
Items 101–200 of 222
Zgierska, A. E., White, V. M., Balles, J. A., Nelson, C., Freedman, J. E., Nguyen, T. H. P., & Johnson, S. C. (2021) · Health & Justice · doi:10.1186/s40352-021-00134-w · Cited by 20
Enhanced Recovery After Surgery in Patients Implanted with Left Ventricular Assist Device
Lindenmuth, D. M., Chase, K., Cheyne, C., Wyrobek, J. A., Bjelic, M., Ayers, B. C., Barrus, B., VanVoorhis, T., McKinley, E. D., Falvey, J., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.05.006 · Cited by 18
Yang, T., Shoff, C. M., Kim, S., & Shaw, B. A. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.114971 · Cited by 20
Concurrent Alcohol and Opioid Use Among Harm Reduction Clients
Winstanley, E. L., Stover, A. N., & Feinberg, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.06.016 · Cited by 17
Large-Scale Social Media Analysis Reveals Emotions Associated with Nonmedical Prescription Drug Use
Al-Garadi, M. A., Yang, Y., Guo, Y., Kim, S., Love, J. S., Perrone, J., & Sarker, A. (2022) · Health Data Science · doi:10.34133/2022/9851989 · Cited by 16
Holmstedt, A., Olsson, M. O., & Håkansson, A. (2020) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2020.100272 · Cited by 15
Ellis, J. D., Pittman, B. P., & McKee, S. A. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108012 · Cited by 14
Alternatives To Opioids For Managing Pain
Dey, S., & Vrooman, B. (2021) · Cited by 14
A Diagram of the Social-Ecological Conditions of Opioid Misuse and Overdose
Brady, B. R., Taj, E. A., Cameron, E., Yoder, A. M., & Rosa, J. S. D. L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20206950 · Cited by 14
Barreno, E. M., López, J. R., Fernández‐Calderón, F., Lozano, O. M., & Díaz, C. (2019) · European Addiction Research · doi:10.1159/000500806 · Cited by 16
Picco, L., Sanfilippo, P. G., Xia, T., Lam, T., & Nielsen, S. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103856 · Cited by 15
Nicholson, H. L. (2020) · Sociological Spectrum · doi:10.1080/02732173.2019.1707138 · Cited by 17
Adejumo, A. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0579 · Cited by 13
Alcohol outlets, drug paraphernalia sales, and neighborhood drug overdose
Nesoff, E. D., Milam, A. J., Morrison, C. N., Weir, B. W., Branas, C. C., Furr‐Holden, D. M., Knowlton, A. R., & Martins, S. S. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103289 · Cited by 13
Coloma‐Carmona, A., Carballo, J. L., Marín, J. R., & Román, C. J. V.-D. H. (2018) · European Journal of Pain · doi:10.1002/ejp.1305 · Cited by 13
Hahn, Y., Tiernan, G., & Berecki‐Gisolf, J. (2018) · Accident Analysis & Prevention · doi:10.1016/j.aap.2018.03.032 · Cited by 12
Braciszewski, J. M., Idu, A., Yarborough, B. J. H., Stumbo, S. P., Bobb, J. F., Bradley, K. A., Rossom, R. C., Murphy, M. T., Binswanger, I. A., Campbell, C. I., et al. (2022) · Psychiatric Services · doi:10.1176/appi.ps.202100665 · Cited by 12
Sajid, A., Whiteman, A., Bell, R. L., Greene, M., Engleman, E. A., & Chambers, R. A. (2016) · American Journal on Addictions · doi:10.1111/ajad.12441 · Cited by 12
Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy
Campbell, C. I., Kline‐Simon, A. H., Korff, M. V., Saunders, K. W., & Weisner, C. M. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2016.1276189 · Cited by 12
Frohe, T. M., Beseler, C. L., Mendoza, A. M., Cottler, L. B., & Leeman, R. F. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000431 · Cited by 13
Health harms of non‐medical prescription opioid use: A systematic review
Werb, D., Scheim, A. I., Soipe, A. I., Aeby, S., Rammohan, I., Fischer, B., Hadland, S. E., & Marshall, B. D. L. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13441 · Cited by 11
Greenwald, M. K., Wiest, K. L., Haight, B. R., Laffont, C. M., & Zhao, Y. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00906-7 · Cited by 11
Hall, N. Y., Le, L. K., Majmudar, I. K., Teesson, M., & Mihalopoulos, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258620 · Cited by 12
Bormann, N. L., Weber, A. N., Arndt, S. V., & Lynch, A. (2023) · American Journal on Addictions · doi:10.1111/ajad.13431 · Cited by 12
Iheanacho, T., Bommersbach, T. J., Fuehrlein, B., Arnaout, B., & Dike, C. C. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00586-8 · Cited by 10
Westenberg, J. N., Tai, A. M. Y., Elsner, J., Kamel, M. M., Wong, J. S. H., Azar, P., Vo, D. X., Moore, E. M., Mathew, N., Seethapathy, V., et al. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13155 · Cited by 10
Carrà, G., Bartoli, F., Galanter, M., & Crocamo, C. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1546533 · Cited by 9
Roberto, K. A., Teaster, P. B., Lindberg, B. W., & Blancato, R. B. (2020) · Journal of Applied Gerontology · doi:10.1177/0733464820947279 · Cited by 9
Socias, M. E., Grant, C. C., Hayashi, K., Bardwell, G., Kennedy, M. C., Milloy, M., & Kerr, T. H. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109109 · Cited by 9
McGirt, M. J., Holland, C. M., Farber, S. H., Zuckerman, S. L., Spertus, M. S., Theodore, N., Pfortmiller, D. T., & Stanley, G. (2023) · North American Spine Society Journal (NASSJ) · doi:10.1016/j.xnsj.2023.100287 · Cited by 12
Strickland, J. C., Staton, M., Leukefeld, C. G., Oser, C. B., & Webster, J. M. (2018) · International Journal of Prisoner Health · doi:10.1108/ijph-03-2017-0012 · Cited by 9
Suicidal ideation, plan, and attempts and nonmedical prescription opioid use among U.S. adults
Kim‐Godwin, Y. S., & Lee, M. H. (2019) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2019.04.009 · Cited by 9
Liu, X., Duan, R., Luo, C., Ogdie, A., Moore, J. H., Kranzler, H. R., Bian, J., & Chen, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-14029-9 · Cited by 8
Kraft, K. V. L., Backmund, T., Eberhart, L. H. J., Schubert, A., Dinges, H., Hagen, M. K., & Gehling, M. (2023) · British Journal of Pain · doi:10.1177/20494637231216352 · Cited by 8
Khazaee-Pool, M., Naghibi, S. A., Pashaei, T., & Ponnet, K. S. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00472-8 · Cited by 8
Nielsen, S., Lintzeris, N., Murnion, B. P., Degenhardt, L. J., Bruno, R., Haber, P., Johnson, J. S., Hardy, M., Ling, S., Sadler, C., et al. (2018) · Drug and Alcohol Review · doi:10.1111/dar.12859 · Cited by 8
Eitan, S., Madison, C. A., & Kuempel, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.019 · Cited by 8
Harter, C., Ness, M., Goldin, A., Lee, C., Merenda, C., Riberdy, A., Saha, A., Araojo, R., & Tarver, M. E. (2023) · JMIR Infodemiology · doi:10.2196/41672 · Cited by 8
Yeh, H.-H. H., Peltz-Rauchman, C., Johnson, C. C., Pawloski, P. A., Chesla, D. W., Waring, S. C., Stevens, A. B., Epstein, M. M., Joseph, C. L. M., Miller-Matero, L. R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290416 · Cited by 11
Understanding differences in prescription drug misuse between two Texas border communities
Martínez, P., Zemore, S. E., Pinedo, M., Borges, G. L. G., Orozco, R., & CHERPITEL, C. J. S. (2019) · Ethnicity and Health · doi:10.1080/13557858.2019.1620175 · Cited by 8
Byllesby, B. M., Haney, A. M., & Asamsama, O. H. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2196575 · Cited by 7
Prenatal heroin exposure alters brain morphology and connectivity in adolescent mice
Hornburg, K. J., Slosky, L. M., Cofer, G. P., Cook, J., Qi, Y. P., Porkka, F., Clark, N. B., Pires, A., Petrella, J. R., WHITE, L. E., et al. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4842 · Cited by 7
Mengers, S., Strony, J. T., Sivasundaram, L., Yu, J., Goodfellow, D. B., Salata, M. J., Voos, J. E., & Karns, M. R. (2022) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-21-00721 · Cited by 7
John, W. S., & Wu, L.-T. T. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1568495 · Cited by 7
Geriatric Opioid Harm Reduction: Interprofessional Student Learning Outcomes
Zanjani, F. A. K., Brooks, M., Waters, L., Parsons, P. L., & Slattum, P. W. (2020) · Gerontology and Geriatric Medicine · doi:10.1177/2333721420908985 · Cited by 7
Ramadan, M. M., Banta, J. E., Bahjri, K. A., & Montgomery, S. (2020) · Journal of Addictive Diseases · doi:10.1080/10550887.2020.1816117 · Cited by 7
Epidemiology of Opioid Use, Misuse, and Overdoses
Draghmeh, K., Gold, M. S., & Fuehrlein, B. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00649-4 · Cited by 6
Chamoun, K., Mouawad, J., Salameh, P., Sacre, H., Haddad, R., Khabbaz, L., Mégarbane, B., & Hajj, A. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05304-8 · Cited by 4
Bi-directional Acceleration of Alcohol Use and Opioid Use Disorder.
Huang, W., Penaherrera, E. P., Desir, D. F., Gamarro, D. L., Cottrell, J. A., Chu, T.-C., & Chang, S. L. (2019) · PubMed · Cited by 6
Badour, C. L., Flores, J., Hood, C. O., Jones, A. C., Brake, C. A., Tipsword, J. M., Penn, C. J., & McCann, J. P. (2022) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0001303 · Cited by 6
Predicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study
Punches, B. E., Stolz, U., Freiermuth, C. E., Ancona, R. M., McLean, S. A., House, S. L., Beaudoin, F. L., An, X., Stevens, J. S., Zeng, D., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273378 · Cited by 6
Individualized risk assessment of preoperative opioid use by interpretable neural network regression
Sun, Y., Kang, J., Brummett, C. M., & Li, Y. (2023) · The Annals of Applied Statistics · doi:10.1214/22-aoas1634 · Cited by 5
Brady, K. T., & Lydiard, J. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_98 · Cited by 6
Treatment of Opioid Use Disorder in Pediatric Medical Settings
Levy, S., & Camenga, D. R. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00272-0 · Cited by 6
Pro, G. C., Giano, Z. D., Camplain, R. L., Haberstroh, S., Camplain, C., Wheeler, D., Hubach, R. D., & Baldwin, J. A. (2020) · Community Mental Health Journal · doi:10.1007/s10597-020-00719-z · Cited by 6
Recent/Childhood Adversities and Mental Disorders Among US Immigrants
Cano, M. N., & Takeuchi, D. T. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.573410 · Cited by 7
Parekh, S. V., Adams, L. O., Barkell, G. A., & Lysle, D. T. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06310-0 · Cited by 6
Persich, P., Engels, G. E., van Oeveren, W., Galia, E., Benay, S., & Thun, S. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104776 · Cited by 5
Reasons for non-medical use of prescription opioids among young adults: Role of educational status
Peck, K. R., Parker, M. A., & Sigmon, S. C. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.03.047 · Cited by 5
Early Childhood Behavioral and Academic Antecedents of Lifetime Opioid Misuse among Urban Youth
Rabinowitz, J. A., Reboussin, B. A., Thrul, J., Drabick, D. A. G., Kahn, G. D., Green, K. M., Ialongo, N. S., Huhn, A. S., & Maher, B. S. (2021) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2021.1875324 · Cited by 5
Cunningham, D. J., Blatter, M., Adams, S. B., & Gage, M. J. (2021) · Injury · doi:10.1016/j.injury.2021.11.039 · Cited by 5
Choi, B. Y., DiNitto, D. M., Marti, C. N., & Choi, N. G. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1557356 · Cited by 5
Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting
Sharma, M., Lee, C. K., Kantorovich, S., Tedtaotao, M., Smith, G. A., & Brenton, A. (2017) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817717411 · Cited by 5
Veliz, P. T., Schulenberg, J. E., Zdroik, J., Werner, K. S., & McCabe, S. E. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac132 · Cited by 4
Axon, D. R., & Grieser, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206684 · Cited by 4
Krishnaswami, S., Mukhopadhyay, S., McPheeters, M. L., & Nechuta, S. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105883 · Cited by 4
Brooks, J., Umucu, E., Fortuna, K. L., Reid, M. C., Tracy, K., & Poghosyan, L. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1855105 · Cited by 4
Patient Activation of Persons With Opioid Use Disorder in Intensive Outpatient Treatment
Keen, A., Lu, Y. Y.-F., Oruche, U. M., Mazurenko, O., & Draucker, C. B. (2022) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903221096473 · Cited by 4
Correlates of death during outpatient treatment for opioid use disorder: A national study
Goldman, J. A., Samuels, E. A., Rich, J. D., & Marshall, B. D. L. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.01.003 · Cited by 4
Unveiling the Controversy: Legal Analysis of Juvenile Narcotics Use for Medical Purposes
Alhakim, A., Febriyani, E., Situmeang, A., & Tan, D. (2023) · Jurnal Jurisprudence · doi:10.23917/jurisprudence.v13i2.3143 · Cited by 3
Suicide deaths involving opioid poisoning in the United States, by sex, 1999-2021
Hoopsick, R. A., Yockey, R. A., Campbell, B. M., Sauda, T. H., & Khan, T. N. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae094 · Cited by 3
Furulund, E., Carlsen, S.-E. L., Alpers, S. E., Vold, J. H., Druckrey-Fiskaaen, K. T., Madebo, T., Dyrstad, S. M., Lid, T. G., & Fadnes, L. T. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00583-w · Cited by 3
Opioid Dependence Risk Factors and Risk Assessment
McAnally, H. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-47497-7_10 · Cited by 3
Description of Opioid-involved Hospital Deaths that Do Not Have a Subsequent Autopsy
Abasilim, C., Holloway‐Beth, A., & Friedman, L. S. (2022) · Epidemiology · doi:10.1097/ede.0000000000001543 · Cited by 3
A gender-based analysis of nonmedical prescription opioid use among people who use illicit drugs
Cheng, T., Nosova, E., Small, W., Hogg, R. S., Hayashi, K., & DeBeck, K. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.05.022 · Cited by 3
Watson, G. L., Selfridge, N. J., & Wright, B. E. (2020) · Health Science Reports · doi:10.1002/hsr2.193 · Cited by 3
Nugraheni, S. E., & Hastings, J. F. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1688351 · Cited by 3
Morgan, J. K., Walther, S. K., & Lane, M. E. (2019) · Psychology · doi:10.4236/psych.2019.1015129 · Cited by 3
Role of Executive Functions in Substance Use Disorder
Ucar, E. N., & Emek‐Savaş, D. D. (2025) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1682854 · Cited by 4
Epidemiology of selected mental disorders in later life
Renn, B. N., Areán, P. A., & Unützer, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00002-8 · Cited by 2
Thrul, J., Rabinowitz, J. A., Reboussin, B. A., Maher, B. S., Anthony, J. C., & Ialongo, N. S. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.01.033 · Cited by 2
Characterization of Infectious Keratitis in Opioid Users in a County Hospital Setting
Lopez, J. B., Chan, L., Saifee, M., Seitzman, G. D., Yung, M., & Chan, M. F. (2023) · Cornea Open · doi:10.1097/coa.0000000000000010 · Cited by 2
Baldwin, L., Mollis, B. L., Witwer, E., Halladay, J. R., Ludden, T., Elder, N. C., Tapp, H., Donahue, K. E., Johnson, D. J., MOTTUS, K. M., et al. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.02.009 · Cited by 2
Substance use disorders in the elderly
Jilk, T. J., & Mumenthaler, M. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00015-6 · Cited by 2
Xiang, A., Rashidian, S., Hou, W., Rosenthal, R. N., Abell-Hart, K., Zhao, X., & Wang, F. (2021) · JMIR Public Health and Surveillance · doi:10.2196/23426 · Cited by 2
Jacobs, D. M., Tober, R., Yu, C., Gibson, W., Dunn, T., Lu, C., Bednzarczyk, E., Jette, G., Lape-Newman, B., Falls, Z., et al. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07682-3 · Cited by 2
Alcohol Use Among Treatment-Seeking Individuals with Opioid Use Disorder
Baskerville, W., Grodin, E. N., Lin, J. W., Miotto, K. A., Mooney, L. J., & Ray, L. A. (2023) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.22-00176 · Cited by 2
Psychoactive prescription drug use disorders, misuse and abuse : Pharmacoepidemiological aspects
Tjäderborn, M. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-130768 · Cited by 2
Leveraging the Prescription Drug Monitoring Program to Curb Opioid Prescribing in Arkansas
Hayes, C. J., Goree, J. H., Turpin, J., Ortiz, H., Smith, G. R., Gokarakonda, S. B., Hyde, C., & Cucciare, M. A. (2022) · Journal of Prevention · doi:10.1007/s10935-022-00670-7 · Cited by 1
Predicting the Onset of Opioid Use Disorder in the Swedish General Population
Kendler, K. S., Lönn, S. L., Sundquist, J., & Sundquist, K. (2022) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2022.83.332 · Cited by 2
Korona-Bailey, J., Moses, J., & Mukhopadhyay, S. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2454653 · Cited by 1
Mogavero, M. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-88816-8_3 · Cited by 1
Twin-Center Study Comparing Stigma Among Males and Females with Alcohol Dependence
Sadashiv, M., Kakunje, A., Karkal, R., & Ganganna, S. (2020) · Asian Journal of Social Health and Behavior · doi:10.4103/shb.shb_14_20 · Cited by 1
Analysis of the Effectiveness of Drug Awareness Campaigns Using Google Trends
Deng, R., & Aslam, M. S. (2020) · Current Trends in Biotechnology and Pharmacy · doi:10.5530/ctbp.2020.4s.21 · Cited by 1
Maisner, R. S., Song, A., Zhou, B., Srinivasan, N., Thepmankorn, P., Siniakowicz, C., & Ayyala, H. S. (2022) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000003077 · Cited by 1
Iheanacho, T., Jordan, A., & Dike, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-33404-8_18 · Cited by 1
Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_29 · Cited by 1
Liang, C. J., Luo, C., Kranzler, H. R., Bian, J., & Chen, Y. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae313 · Cited by 1
Harris, D. R., Shrestha, S., Rock, P. J., Silwal, A., Barboza-Salerno, G., Lewis, O., Srinivasan, S., & Stopka, T. J. (2025) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2025.209625 · Cited by 1
MacNeill, L., Doucet, S. A., & Luke, A. (2021) · Journal of Substance Use · doi:10.1080/14659891.2021.1941349 · Cited by 1
Metadata
- Authors
- Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., Hasin, D. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Columbia University (US)
- New York State Psychiatric Institute (US)
- Corresponding author
- Saha, Tulshi D.
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2016-06-22
- Volume
- 77
- Issue
- 06
- Pages
- 772-780
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC5555044
- OpenAlex
- W2468306238
- Cited by
- 222
- References
- 85
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 6 · 2023: 20 · 2022: 22 · 2021: 31 · 2020: 45 · 2019: 32 · 2018: 28 · 2017: 21 · 2016: 4
- FWCI
- 28.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (Z01AA000449)
- National Institute on Drug Abuse (R01DA034244, F32DA036431)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- prescription opioid misuse, prevalence, psychiatric comorbidity, post-traumatic stress disorder, personality disorders, major depressive disorder, bipolar I disorder, treatment utilization, risk factors, NESARC-III, DSM-5
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Cross-Sectional Studies, Female, Health Surveys, Humans, Male, Middle Aged, Opioid-Related Disorders, Statistics as Topic, United States, Comorbidity, Diagnostic and Statistical Manual of Mental Disorders, Young Adult, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review